scholarly journals First in human, a phase I study of ISU104, a novel ErbB3 monoclonal antibody, in patients with advanced solid tumours

2019 ◽  
Vol 30 ◽  
pp. v168
Author(s):  
S.-B. Kim ◽  
B. Keam ◽  
S. Shin ◽  
Y.S. Chae ◽  
T.M. Kim ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Phase I Study ◽  
Solid Tumours

Intravenous administration of CP-4055 (ELACYT™) in patients with solid tumours. A phase I study

2009 ◽  
Vol 48 (1) ◽  
pp. 137-145 ◽  
Author(s):  
Svein Dueland ◽  
Steinar Aamdal ◽  
Michael J. Lind ◽  
Hilary Thomas ◽  
Marit Liland Sandvold ◽  
...  
Keyword(s):  
Phase I ◽  
Intravenous Administration ◽  
Phase I Study ◽  
Solid Tumours

Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study

2017 ◽  
Vol 85 ◽  
pp. 39-48 ◽  
Author(s):  
Alain Ravaud ◽  
Carlos Gomez-Roca ◽  
Marie-Quitterie Picat ◽  
Laurence Digue ◽  
Christine Chevreau ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Study ◽  
Solid Tumours

scholarly journals Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours

2013 ◽  
Vol 108 (10) ◽  
pp. 1998-2004 ◽  
Author(s):  
M Millward ◽  
C Underhill ◽  
S Lobb ◽  
J McBurnie ◽  
S J Meech ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Solid Tumours
Sign in / Sign up

Export Citation Format

Share Document